TOP CATEGORY: Chemicals & Materials | Life Sciences | Banking & Finance | ICT Media

United States Breast Cancer Liquid Biopsy Market Research Report 2023

United States Breast Cancer Liquid Biopsy Market Research Report 2023

  • Category:Life Sciences
  • Published on : 02 May 2023
  • Pages :91
  • Formats:
  • Report Code:SMR-7670677
OfferClick for best price

Best Price: $2320

Breast Cancer Liquid Biopsy Market Size, Share 2023


Market Analysis and Insights: Global Breast Cancer Liquid Biopsy Market

The global Breast Cancer Liquid Biopsy market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.

With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Breast Cancer Liquid Biopsy market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Breast Cancer Liquid Biopsy market in terms of revenue.

On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Breast Cancer Liquid Biopsy market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Breast Cancer Liquid Biopsy market.

Global Breast Cancer Liquid Biopsy Scope and Market Size

The United States Breast Cancer Liquid Biopsy market is projected to grow from US$ billion in 2023 to US$ billion by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

This report contains market size and forecasts of Breast Cancer Liquid Biopsy in global, including the following market information:

United States Breast Cancer Liquid Biopsy Market Revenue, 2018-2023, 2023-2032, ($ millions)

United States Breast Cancer Liquid Biopsy Market Sales, 2018-2023, 2023-2032,

United States top five Breast Cancer Liquid Biopsy companies in 2022 (%)

The United States Breast Cancer Liquid Biopsy market was valued at million in 2022 and is projected to reach US$ million by 2032, at a CAGR of % during the forecast period 2023-2032.

Report Includes

This report presents an overview of United States market for Breast Cancer Liquid Biopsy , sales, revenue and price. Analyses of the United States market trends, with historic market revenue/sales data for 2018 - 2022, estimates for 2023, and projections of CAGR through 2032.

This report focuses on the Breast Cancer Liquid Biopsy sales, revenue, market share and industry ranking of main manufacturers, data from 2018 to 2023. Identification of the major stakeholders in the United States Breast Cancer Liquid Biopsy market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues.

This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type, and by Sales Channels, sales, revenue, and price, from 2018 to 2032. Evaluation and forecast the market size for Humidifier sales, projected growth trends, production technology, sales channels and end-user industry.

Segment by Type

Circulating Tumor Cells (CTCs)

Cell-Free DNA (CfDNA)

Extracellular Vesicles (EVs)

Other Circulating Biomarkers

Segment by Applications

Hospitals

Diagnostic Centers

Laboratories

Key Companies covered in this report:

  • Company 1
  • Company 2
  • Company 3
  • Company 4
  • Company 5
  • Company 6
  • Company 7
  • Company 8
  • Company 9
  • Company 10

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Breast Cancer Liquid Biopsy revenues in global market, 2018-2023 (Estimated), ($ millions)

Key companies Breast Cancer Liquid Biopsy revenues share in global market, 2022 (%)

Key companies Breast Cancer Liquid Biopsy sales in global market, 2018-2023 (Estimated),

Key companies Breast Cancer Liquid Biopsy sales share in global market, 2022 (%)

The information for each competitor/Company Profile includes:

  • Company Overview
  • Business Strategy
  • Key Product Offerings
  • Financial Performance
  • Key Performance Indicators
  • Risk Analysis
  • Recent Development
  • Regional Presence
  • SWOT Analysis 

The content of the study subjects includes a total of 15 chapters:

Chapter 1, describes Breast Cancer Liquid Biopsy product scope, market overview, market opportunities, market driving force, and market risks.

Chapter 2, profiles the top manufacturers of Breast Cancer Liquid Biopsy, with price, sales, revenue, and global market share of Breast Cancer Liquid Biopsy from 2019 to 2022.

Chapter 3, the Breast Cancer Liquid Biopsy competitive situation, sales, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.

Chapter 4, the Breast Cancer Liquid Biopsy breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.

Chapters 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, and application, from 2017 to 2028.

Chapters 7, 8, 9, 10, and 11, to break the sales data at the country level, with sales, revenue, and market share for key countries in the world, from 2017 to 2022. and the Breast Cancer Liquid Biopsy market forecast, by regions, type, and application, with sales and revenue, from 2023 to 2028.

Chapter 12, the key raw materials and key suppliers, and industry chain of Breast Cancer Liquid Biopsy.

Chapter 13, 14, and 15, to describe Breast Cancer Liquid Biopsy sales channel, distributors, customers, research findings and conclusion, appendix and data source.

Key Indicators Analysed:

  • Market Players & Competitor Analysis: The report covers the key players of the industry including Company Profile, Product Specifications, Production Capacity/Sales, Revenue, Price and Gross Margin 2016-2027 & Sales with a thorough analysis of the market?s competitive landscape and detailed information on vendors and comprehensive details of factors that will challenge the growth of major market vendors.
  • Global and Regional Market Analysis: The report includes Global & Regional market status and outlook 2016-2027. Further the report provides break down details about each region & countries covered in the report. Identifying its sales, sales volume & revenue forecast. With detailed analysis by types and applications.
  • Market Trends: Market key trends which include Increased Competition and Continuous Innovations.
  • Opportunities and Drivers: Identifying the Growing Demands and New Technology
  • Porters Five Force Analysis: The report provides with the state of competition in industry depending on five basic forces: threat of new entrants, bargaining power of suppliers, bargaining power of buyers, threat of substitute products or services, and existing industry rivalry.

Reasons to Purchase this Report:

  • Estimates 2022-2027 2021-2025 Breast Cancer Liquid Biopsy Report on, Status and Forecast, by Players, Types and Applications market development trends with the recent trends and SWOT analysis
  • Market dynamics scenario, along with growth opportunities of the market in the years to come
  • Market segmentation analysis including qualitative and quantitative research incorporating the impact of economic and policy aspects
  • Regional and country level analysis integrating the demand and supply forces that are influencing the growth of the market.
  • Market value (USD Million) and volume (Units Million) data for each segment and sub-segment
  • Competitive landscape involving the market share of major players, along with the new projects and strategies adopted by players in the past five years
  • Comprehensive company profiles covering the product offerings, key financial information, recent developments, SWOT analysis, and strategies employed by the major market players
  • 1-year analyst support, along with the data support in excel format.

Research Methodology:

The research methodology used to estimate and forecast this market begins by capturing the revenues of the key players and their shares in the market. Various secondary sources such as press releases, annual reports, non-profit organizations, industry associations, governmental agencies and customs data, have been used to identify and collect information useful for this extensive commercial study of the market. Calculations based on this led to the overall market size. After arriving at the overall market size, the total market has been split into several segments and subsegments, which have then been verified through primary research by conducting extensive interviews with industry experts such as CEOs, VPs, directors, and executives. The data triangulation and market breakdown procedures have been employed to complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments.

Report Attributes Report Details
Report Title United States Breast Cancer Liquid Biopsy Market Research Report 2023
Historical Year 2018 to 2022 (Data from 2010 can be provided as per availability)
Base Year 2022
Forecast Year 2030
Number of Pages 91 Pages
Customization Available Yes, the report can be customized as per your need.

TABLE OF CONTENTS

1 STUDY COVERAGE
1.1 Breast Cancer Liquid Biopsy Product Introduction
1.2 Market by Type
1.2.1 United States Breast Cancer Liquid Biopsy Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Type1
1.2.3 Type2
1.3 Market by Application1.3.1 United States Breast Cancer Liquid Biopsy Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Application 1
1.3.3 Application 2
1.4 United States Breast Cancer Liquid Biopsy Sales Estimates and Forecasts 2017-20281.5 United States Breast Cancer Liquid Biopsy Hydrocephalus Shunts Revenue Estimates and Forecasts 2017-2028
1.6 Study Objectives
1.7 Years Considered

2 COMPETITION BY MANUFACTURERS
2.1 United States Breast Cancer Liquid Biopsy Sales by Manufacturers
2.1.1 United States Breast Cancer Liquid Biopsy Sales by Manufacturers (2017-2022)2.1.2 United States Breast Cancer Liquid Biopsy Sales Market Share by Manufacturers (2017-2022)
2.1.3 Top Largest Manufacturers of Breast Cancer Liquid Biopsy in 2021 in United States2.2 United States Breast Cancer Liquid Biopsy Revenue by Manufacturers
2.2.1 United States Breast Cancer Liquid Biopsy Revenue by Manufacturers (2017-2022)2.2.2 United States Breast Cancer Liquid Biopsy Revenue Market Share by Manufacturers (2017-2022)
2.2.3 United States Top Companies by Breast Cancer Liquid Biopsy Revenue in 20212.3 United States Breast Cancer Liquid Biopsy Sales Price by Manufacturers (2017-2022)
2.4 Analysis of Competitive Landscape
2.4.1 Manufacturers Market Concentration Ratio (CR3 and HHI)2.4.2 United States Breast Cancer Liquid Biopsy by Company Type (Tier 1, Tier 2, and Tier 3)
2.4.3 United States Breast Cancer Liquid Biopsy Manufacturers Geographical Distribution
2.5 Mergers & Acquisitions, Expansion Plans

3 UNITED STATES Breast Cancer Liquid Biopsy MARKET SIZE BY REGION
3.1 Breast Cancer Liquid Biopsy Market Size by Region: 2017-2028
3.1.1 United States Breast Cancer Liquid Biopsy Sales by Region: 2017-20223.1.2 United States Breast Cancer Liquid Biopsy Sales Forecast by Region (2023-2028)
3.1.3 United States Breast Cancer Liquid Biopsy Revenue by Region: 2017-2022
3.1.4 United States Breast Cancer Liquid Biopsy Revenue Forecast by Region (2023-2028)3.2 Northeast Breast Cancer Liquid Biopsy Sales and Revenue Growth (2017-2028)
3.3 South Breast Cancer Liquid Biopsy Sales and Revenue Growth (2017-2028)
3.4 Midwest Breast Cancer Liquid Biopsy Sales and Revenue Growth (2017-2028)3.5 West Breast Cancer Liquid Biopsy Sales and Revenue Growth (2017-2028)

4 MARKET SIZE BY TYPE
4.1 United States Breast Cancer Liquid Biopsy Sales by Type4.1.1 United States Breast Cancer Liquid Biopsy Historical Sales by Type (2017-2022)
4.1.2 United States Breast Cancer Liquid Biopsy Forecasted Sales by Type (2023-2028)
4.1.3 United States Breast Cancer Liquid Biopsy Sales Market Share by Type (2017-2028)4.2 United States Breast Cancer Liquid Biopsy Revenue by Type
4.2.1 United States Breast Cancer Liquid Biopsy Historical Revenue by Type (2017-2022)
4.2.2 United States Breast Cancer Liquid Biopsy Forecasted Revenue by Type (2023-2028)4.2.3 United States Breast Cancer Liquid Biopsy Revenue Market Share by Type (2017-2028)
4.3 United States Breast Cancer Liquid Biopsy Price by Type
4.3.1 United States Breast Cancer Liquid Biopsy Price by Type (2017-2022)4.3.2 United States Breast Cancer Liquid Biopsy Price Forecast by Type (2023-2028)

5 MARKET SIZE BY APPLICATION
5.1 United States Breast Cancer Liquid Biopsy Sales by Application5.1.1 United States Breast Cancer Liquid Biopsy Historical Sales by Application (2017-2022)
5.1.2 United States Breast Cancer Liquid Biopsy Forecasted Sales by Application (2023-2028)
5.1.3 United States Breast Cancer Liquid Biopsy Sales Market Share by Application (2017-2028)5.2 United States Breast Cancer Liquid Biopsy Revenue by Application
5.2.1 United States Breast Cancer Liquid Biopsy Historical Revenue by Application (2017-2022)
5.2.2 United States Breast Cancer Liquid Biopsy Forecasted Revenue by Application (2023-2028)5.2.3 United States Breast Cancer Liquid Biopsy Revenue Market Share by Application (2017-2028)
5.3 United States Breast Cancer Liquid Biopsy Price by Application
5.3.1 United States Breast Cancer Liquid Biopsy Price by Application (2017-2022)5.3.2 United States Breast Cancer Liquid Biopsy Price Forecast by Application (2023-2028)

6 CORPORATE PROFILE
6.1 Company16.1.1 Company 1 Corporation Information
6.1.2 Company 1 Overview
6.1.3 Company 1 in United States: Breast Cancer Liquid Biopsy Sales, Price, Revenue and Gross Margin (2017-2022)6.1.4 Company 1 Breast Cancer Liquid Biopsy Product Introduction
6.1.5 Company 1 Recent Developments
6.2 Company 2
6.2.1 Company 2 Corporation Information
6.2.2 Company 2 Overview6.2.3 Company 2 in United States: Breast Cancer Liquid Biopsy Sales, Price, Revenue and Gross Margin (2017-2022)
6.2.4 Company 2 Breast Cancer Liquid Biopsy Product Introduction
6.2.5 Company 2 Recent Developments
6.3 Company 3
6.3.1 Company 3 Corporation Information6.3.2 Company 3 Overview
6.3.3 Company 3 in United States: Breast Cancer Liquid Biopsy Sales, Price, Revenue and Gross Margin (2017-2022)
6.3.4 Company 3 Breast Cancer Liquid Biopsy Product Introduction
6.3.5 Company 3 Recent Developments
6.4 Company 36.4.1 Company 4 Corporation Information
6.4.2 Company 4 Overview
6.4.3 Company 4 in United States: Breast Cancer Liquid Biopsy Sales, Price, Revenue and Gross Margin (2017-2022)
6.4.4 Company 4 Breast Cancer Liquid Biopsy Product Introduction
6.4.5 Company 4 Recent Developments

7 INDUSTRY CHAIN AND SALES CHANNELS ANALYSIS
7.1 Breast Cancer Liquid Biopsy Industry Chain Analysis
7.2 Breast Cancer Liquid Biopsy Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers7.3 Breast Cancer Liquid Biopsy Production Mode & Process
7.4 Breast Cancer Liquid Biopsy Sales and Marketing
7.4.1 Breast Cancer Liquid Biopsy Sales Channels
7.4.2 Breast Cancer Liquid Biopsy Distributors
7.5 Breast Cancer Liquid Biopsy Customers

8 Breast Cancer Liquid Biopsy MARKET DYNAMICS
8.1.1 Breast Cancer Liquid Biopsy Industry Trends
8.1.2 Breast Cancer Liquid Biopsy Market Drivers
8.1.3 Breast Cancer Liquid Biopsy Market Challenges
8.1.4 Breast Cancer Liquid Biopsy Market Restraints

9 KEY FINDINGS IN THE UNITED STATES Breast Cancer Liquid Biopsy STUDY

10 APPENDIX
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer

LIST OF TABLES & FIGURES

List of Tables
Table 1. Global Breast Cancer Liquid Biopsy Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
Table 2. Key Players of Circulating Tumor Cells (CTCs)
Table 3. Key Players of Cell-Free DNA (CfDNA)
Table 4. Key Players of Extracellular Vesicles (EVs)
Table 5. Key Players of Other Circulating Biomarkers
Table 6. Global Breast Cancer Liquid Biopsy Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
Table 7. Global Breast Cancer Liquid Biopsy Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 8. Global Breast Cancer Liquid Biopsy Market Size by Region (2017-2022) & (US$ Million)
Table 9. Global Breast Cancer Liquid Biopsy Market Share by Region (2017-2022)
Table 10. Global Breast Cancer Liquid Biopsy Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 11. Global Breast Cancer Liquid Biopsy Market Share by Region (2023-2028)
Table 12. Breast Cancer Liquid Biopsy Market Trends
Table 13. Breast Cancer Liquid Biopsy Market Drivers
Table 14. Breast Cancer Liquid Biopsy Market Challenges
Table 15. Breast Cancer Liquid Biopsy Market Restraints
Table 16. Global Breast Cancer Liquid Biopsy Revenue by Players (2017-2022) & (US$ Million)
Table 17. Global Breast Cancer Liquid Biopsy Market Share by Players (2017-2022)
Table 18. Global Top Breast Cancer Liquid Biopsy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Breast Cancer Liquid Biopsy as of 2021)
Table 19. Ranking of Global Top Breast Cancer Liquid Biopsy Companies by Revenue (US$ Million) in 2021
Table 20. Global 5 Largest Players Market Share by Breast Cancer Liquid Biopsy Revenue (CR5 and HHI) & (2017-2022)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Breast Cancer Liquid Biopsy Product Solution and Service
Table 23. Date of Enter into Breast Cancer Liquid Biopsy Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Breast Cancer Liquid Biopsy Market Size by Type (2017-2022) & (US$ Million)
Table 26. Global Breast Cancer Liquid Biopsy Revenue Market Share by Type (2017-2022)
Table 27. Global Breast Cancer Liquid Biopsy Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 28. Global Breast Cancer Liquid Biopsy Revenue Market Share by Type (2023-2028)
Table 29. Global Breast Cancer Liquid Biopsy Market Size by Application (2017-2022) & (US$ Million)
Table 30. Global Breast Cancer Liquid Biopsy Revenue Market Share by Application (2017-2022)
Table 31. Global Breast Cancer Liquid Biopsy Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 32. Global Breast Cancer Liquid Biopsy Revenue Market Share by Application (2023-2028)
Table 33. North America Breast Cancer Liquid Biopsy Market Size by Country (2017-2022) & (US$ Million)
Table 34. North America Breast Cancer Liquid Biopsy Market Size by Country (2023-2028) & (US$ Million)
Table 35. Europe Breast Cancer Liquid Biopsy Market Size by Country (2017-2022) & (US$ Million)
Table 36. Europe Breast Cancer Liquid Biopsy Market Size by Country (2023-2028) & (US$ Million)
Table 37. Asia-Pacific Breast Cancer Liquid Biopsy Market Size by Region (2017-2022) & (US$ Million)
Table 38. Asia-Pacific Breast Cancer Liquid Biopsy Market Size by Region (2023-2028) & (US$ Million)
Table 39. Latin America Breast Cancer Liquid Biopsy Market Size by Country (2017-2022) & (US$ Million)
Table 40. Latin America Breast Cancer Liquid Biopsy Market Size by Country (2023-2028) & (US$ Million)
Table 41. Middle East & Africa Breast Cancer Liquid Biopsy Market Size by Country (2017-2022) & (US$ Million)
Table 42. Middle East & Africa Breast Cancer Liquid Biopsy Market Size by Country (2023-2028) & (US$ Million)
Table 43. QIAGEN Company Detail
Table 44. QIAGEN Business Overview
Table 45. QIAGEN Breast Cancer Liquid Biopsy Product
Table 46. QIAGEN Revenue in Breast Cancer Liquid Biopsy Business (2017-2022) & (US$ Million)
Table 47. QIAGEN Recent Development
Table 48. Roche Diagnostics Company Detail
Table 49. Roche Diagnostics Business Overview
Table 50. Roche Diagnostics Breast Cancer Liquid Biopsy Product
Table 51. Roche Diagnostics Revenue in Breast Cancer Liquid Biopsy Business (2017-2022) & (US$ Million)
Table 52. Roche Diagnostics Recent Development
Table 53. Bio-Rad Laboratories Company Detail
Table 54. Bio-Rad Laboratories Business Overview
Table 55. Bio-Rad Laboratories Breast Cancer Liquid Biopsy Product
Table 56. Bio-Rad Laboratories Revenue in Breast Cancer Liquid Biopsy Business (2017-2022) & (US$ Million)
Table 57. Bio-Rad Laboratories Recent Development
Table 58. Myriad Genetics Company Detail
Table 59. Myriad Genetics Business Overview
Table 60. Myriad Genetics Breast Cancer Liquid Biopsy Product
Table 61. Myriad Genetics Revenue in Breast Cancer Liquid Biopsy Business (2017-2022) & (US$ Million)
Table 62. Myriad Genetics Recent Development
Table 63. Menarini Silicon Biosystems Company Detail
Table 64. Menarini Silicon Biosystems Business Overview
Table 65. Menarini Silicon Biosystems Breast Cancer Liquid Biopsy Product
Table 66. Menarini Silicon Biosystems Revenue in Breast Cancer Liquid Biopsy Business (2017-2022) & (US$ Million)
Table 67. Menarini Silicon Biosystems Recent Development
Table 68. Genomic Health Company Detail
Table 69. Genomic Health Business Overview
Table 70. Genomic Health Breast Cancer Liquid Biopsy Product
Table 71. Genomic Health Revenue in Breast Cancer Liquid Biopsy Business (2017-2022) & (US$ Million)
Table 72. Genomic Health Recent Development
Table 73. Thermo Fisher Scientific Company Detail
Table 74. Thermo Fisher Scientific Business Overview
Table 75. Thermo Fisher Scientific Breast Cancer Liquid Biopsy Product
Table 76. Thermo Fisher Scientific Revenue in Breast Cancer Liquid Biopsy Business (2017-2022) & (US$ Million)
Table 77. Thermo Fisher Scientific Recent Development
Table 78. Illumina Company Detail
Table 79. Illumina Business Overview
Table 80. Illumina Breast Cancer Liquid Biopsy Product
Table 81. Illumina Revenue in Breast Cancer Liquid Biopsy Business (2017-2022) & (US$ Million)
Table 82. Illumina Recent Development
Table 83. Biocept Company Detail
Table 84. Biocept Business Overview
Table 85. Biocept Breast Cancer Liquid Biopsy Product
Table 86. Biocept Revenue in Breast Cancer Liquid Biopsy Business (2017-2022) & (US$ Million)
Table 87. Biocept Recent Development
Table 88. Trovagene Company Detail
Table 89. Trovagene Business Overview
Table 90. Trovagene Breast Cancer Liquid Biopsy Product
Table 91. Trovagene Revenue in Breast Cancer Liquid Biopsy Business (2017-2022) & (US$ Million)
Table 92. Trovagene Recent Development
Table 93. Guardant Health Company Detail
Table 94. Guardant Health Business Overview
Table 95. Guardant Health Breast Cancer Liquid BiopsyProduct
Table 96. Guardant Health Revenue in Breast Cancer Liquid Biopsy Business (2017-2022) & (US$ Million)
Table 97. Guardant Health Recent Development
Table 98. RainDance Technologies Company Detail
Table 99. RainDance Technologies Business Overview
Table 100. RainDance Technologies Breast Cancer Liquid BiopsyProduct
Table 101. RainDance Technologies Revenue in Breast Cancer Liquid Biopsy Business (2017-2022) & (US$ Million)
Table 102. RainDance Technologies Recent Development
Table 103. MDx Health Company Detail
Table 104. MDx Health Business Overview
Table 105. MDx Health Breast Cancer Liquid BiopsyProduct
Table 106. MDx Health Revenue in Breast Cancer Liquid Biopsy Business (2017-2022) & (US$ Million)
Table 107. MDx Health Recent Development
Table 108. Research Programs/Design for This Report
Table 109. Key Data Information from Secondary Sources
Table 110. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Breast Cancer Liquid Biopsy Market Share by Type: 2021 VS 2028
Figure 2. Circulating Tumor Cells (CTCs) Features
Figure 3. Cell-Free DNA (CfDNA) Features
Figure 4. Extracellular Vesicles (EVs) Features
Figure 5. Other Circulating Biomarkers Features
Figure 6. Global Breast Cancer Liquid Biopsy Market Share by Application in 2021 & 2028
Figure 7. Hospitals Case Studies
Figure 8. Diagnostic Centers Case Studies
Figure 9. Laboratories Case Studies
Figure 10. Breast Cancer Liquid Biopsy Report Years Considered
Figure 11. Global Breast Cancer Liquid Biopsy Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 12. Global Breast Cancer Liquid Biopsy Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 13. Global Breast Cancer Liquid Biopsy Market Share by Region: 2021 VS 2028
Figure 14. Global Breast Cancer Liquid Biopsy Market Share by Players in 2021
Figure 15. Global Top Breast Cancer Liquid Biopsy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Breast Cancer Liquid Biopsy as of 2021)
Figure 16. The Top 10 and 5 Players Market Share by Breast Cancer Liquid Biopsy Revenue in 2021
Figure 17. North America Breast Cancer Liquid Biopsy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 18. North America Breast Cancer Liquid Biopsy Market Share by Country (2017-2028)
Figure 19. United States Breast Cancer Liquid Biopsy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 20. Canada Breast Cancer Liquid Biopsy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 21. Europe Breast Cancer Liquid Biopsy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 22. Europe Breast Cancer Liquid Biopsy Market Share by Country (2017-2028)
Figure 23. Germany Breast Cancer Liquid Biopsy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 24. France Breast Cancer Liquid Biopsy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 25. U.K. Breast Cancer Liquid Biopsy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 26. Italy Breast Cancer Liquid Biopsy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 27. Russia Breast Cancer Liquid Biopsy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 28. Nordic Countries Breast Cancer Liquid Biopsy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 29. Asia-Pacific Breast Cancer Liquid Biopsy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 30. Asia-Pacific Breast Cancer Liquid Biopsy Market Share by Region (2017-2028)
Figure 31. China Breast Cancer Liquid Biopsy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 32. Japan Breast Cancer Liquid Biopsy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 33. South Korea Breast Cancer Liquid Biopsy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 34. Southeast Asia Breast Cancer Liquid Biopsy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 35. India Breast Cancer Liquid Biopsy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 36. Australia Breast Cancer Liquid Biopsy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 37. Latin America Breast Cancer Liquid Biopsy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 38. Latin America Breast Cancer Liquid Biopsy Market Share by Country (2017-2028)
Figure 39. Mexico Breast Cancer Liquid Biopsy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 40. Brazil Breast Cancer Liquid Biopsy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 41. Middle East & Africa Breast Cancer Liquid Biopsy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 42. Middle East & Africa Breast Cancer Liquid Biopsy Market Share by Country (2017-2028)
Figure 43. Turkey Breast Cancer Liquid Biopsy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 44. Saudi Arabia Breast Cancer Liquid Biopsy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 45. QIAGEN Revenue Growth Rate in Breast Cancer Liquid Biopsy Business (2017-2022)
Figure 46. Roche Diagnostics Revenue Growth Rate in Breast Cancer Liquid Biopsy Business (2017-2022)
Figure 47. Bio-Rad Laboratories Revenue Growth Rate in Breast Cancer Liquid Biopsy Business (2017-2022)
Figure 48. Myriad Genetics Revenue Growth Rate in Breast Cancer Liquid Biopsy Business (2017-2022)
Figure 49. Menarini Silicon Biosystems Revenue Growth Rate in Breast Cancer Liquid Biopsy Business (2017-2022)
Figure 50. Genomic Health Revenue Growth Rate in Breast Cancer Liquid Biopsy Business (2017-2022)
Figure 51. Thermo Fisher Scientific Revenue Growth Rate in Breast Cancer Liquid Biopsy Business (2017-2022)
Figure 52. Illumina Revenue Growth Rate in Breast Cancer Liquid Biopsy Business (2017-2022)
Figure 53. Biocept Revenue Growth Rate in Breast Cancer Liquid Biopsy Business (2017-2022)
Figure 54. Trovagene Revenue Growth Rate in Breast Cancer Liquid Biopsy Business (2017-2022)
Figure 55. Guardant Health Revenue Growth Rate in Breast Cancer Liquid Biopsy Business (2017-2022)
Figure 56. RainDance Technologies Revenue Growth Rate in Breast Cancer Liquid Biopsy Business (2017-2022)
Figure 57. MDx Health Revenue Growth Rate in Breast Cancer Liquid Biopsy Business (2017-2022)
Figure 58. Bottom-up and Top-down Approaches for This Report
Figure 59. Data Triangulation
Figure 60. Key Executives Interviewed

REPORT PURCHASE OPTIONS

USD Single User Price
USD Multi User Price
USD Enterprise Price

---- OR ----

Frequently Asked Questions ?

  • Upto 24 hrs - Working days
  • Upto 48 hrs max - Weekends and public holidays
  • Single User License
    A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.

  • Multi user License
    A license granted to multiple users.

  • Site License
    A license granted to a single business site/establishment.

  • Corporate License, Global License
    A license granted to all employees within organisation access to the product.
  • Online Payments with PayPal and CCavenue
  • Wire Transfer/Bank Transfer
  • Email
  • Hard Copy

Our Key Features

  • Data Accuracy and Reliability
  • Data Security
  • Customized Research
  • Trustworthy
  • Competitive Offerings
check discount